2018 CVM News: Provost Kotlikoff part of international research effort to prevent heart arrhythmia
| dc.contributor.author | Office of Marketing and Communications. Media Relations | |
| dc.date.accessioned | 2018-06-07T18:39:04Z | |
| dc.date.available | 2018-06-07T18:39:04Z | |
| dc.date.issued | 2018-05-08 | |
| dc.description.abstract | This news item from the Cornell Chronicle is about: The most common and potentially lethal complication following a heart attack is the heart's inability to do one of its most basic jobs: beat at a normal rate. Following myocardial infarction, heart muscle cells are replaced by fibroblasts and new blood vessels, which do not conduct electricity and leave the heart susceptible to ventricular tachycardia - an excessive heart rate that can result in sudden death. These non-heart cells disrupt the normal pattern of electrical conduction that is critical for effective pumping. If there were a way to make these cells electrically active, one could bridge the conduction block to a certain degree, and greatly decrease dangerous post-infarction complications. Provost Michael Kotlikoff - a professor in the Department of Biomedical Sciences in the Provost Michael Kotlikoff College of Veterinary Medicine - is part of an international collaboration that is aiming to bridge that gap in damaged hearts with a simple gene-therapy approach. | |
| dc.identifier.uri | https://hdl.handle.net/1813/57289 | |
| dc.language.iso | en_US | |
| dc.publisher | Cornell University, College of Veterinary Medicine | |
| dc.subject | Cornell University. College of Veterinary Medicine -- Periodicals. | |
| dc.subject | Kotlikoff, Michael I. | |
| dc.subject | Fleischman, Tom | |
| dc.subject | Cornell Chronicle | |
| dc.title | 2018 CVM News: Provost Kotlikoff part of international research effort to prevent heart arrhythmia | |
| dc.type | article |